Oh for fucking stupidity. 'Costs'. YOU have to correct their stupid ideas and get them to solve stroke, 100% recovery for all.
Pilot study into individualised digital stroke rehab tool launches to help save NHS money
Led by the University of Central Lancashire (UCLan), a pilot research study into a potentially life-enhancing digital stroke rehabilitation tool has launched.
The Virtual Engagement Rehabilitation Assistant (VERA) is a bespoke digital tool being developed by The Walton Centre NHS Foundation Trust and Citrus Suite software company, with research, funded by The Stroke Association and MedCity, led by UCLan.
Through an individualised programme, VERA aims to vastly improve patient recovery and how survivors adapt to life after a stroke.
It allows mobile devices to access a range of applications to support rehabilitation and provides patient information, images and videos to guide bespoke personalised exercises, treatment information, a daily schedule and support.
It is hoped the tool will empower stroke survivors by improving their understanding of rehabilitation and increasing their personal motivation and opportunity to participate in therapy. By streamlining the process, VERA aims to increase the availability of rehabilitation therapy to stroke survivors, help healthcare professionals use their time more effectively, and, ultimately, save the NHS money.
Dr Ganesh Bavikatte, Consultant and Clinical Lead in Rehabilitation Medicine at The Walton Centre NHS Foundation Trust, said: “Every patient who goes through the rehabilitation journey with The Walton Centre and our partners in the Cheshire and Merseyside Rehab Network, has a different experience. It is really personal to them.
“This digital tool will help us provide a bespoke process for each patient which will support our teams to provide the very best rehabilitation and therapy programme.”
The pilot study has already begun. It aims to investigate VERA to identify who might benefit from, and to better understand, this digital technology.
Dr Kathryn Jarvis, Senior Lecturer in Occupational Therapy at UCLan, is the research lead on the project.
She commented: “We have worked closely with stroke survivors and healthcare professionals to develop VERA and the supporting training materials. In the study, we will gauge how VERA could be used to increase activity and functional recovery in neurological rehabilitation. In addition, we will explore how VERA can be implemented in a complex neurological in-patient setting.”
The initial idea for VERA came from a hackathon held in 2018 at The Walton Centre and was then developed in a partnership between The Walton Centre NHS Foundation Trust, UCLan and, at a later stage, Citrus Suite. The Walton Centre Charity provided £37,000 to develop a prototype, and funding of almost £60,000 to test the research came from The Stroke Association and Med City.
Richard Francis, Head of Research at the Stroke Association, added: “We are delighted to be funding this exciting virtual rehabilitation project in partnership with MedCity.
“As a charity we know the vitally important part research plays to ensure stroke survivors can access the latest and best rehabilitation after stroke. Every stroke is different and so is every recovery, so personalising therapy is key to helping stroke make the best possible recovery.
“We know that stroke survivors are still not accessing all the rehabilitation they need, which has only been made worse by the pandemic. That’s why funding these new technologies could help improve and increase access to personalised rehabilitation.
“Stroke strikes every five minutes and it changes lives in an instant. There are now 1.3 million stroke survivors living in the UK and we believe that everyone deserves to live the best life they can after stroke.”
The results of the study will be published later this year.
A recent US study showed that a digital care rehabilitation programme for people with chronic shoulder pain clinically significantly improved all health-related outcomes. By the end of the 12-week virtual programme, a mean reduction of 51.6 percent in disability and symptom severity was observed across study participants.
No comments:
Post a Comment